# Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers

> **NCT03822884** · PHASE1 · COMPLETED · sponsor: **Bio Sidus SA** · enrollment: 24 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Epoetin Alfa 40000 UNT/ML

## Key facts

- **NCT ID:** NCT03822884
- **Lead sponsor:** Bio Sidus SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03822884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03822884, "Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03822884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*